X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-point-biopharma-302022791.html
https://www.pointbiopharma.com/press-releases/splash-topline-results
https://www.globenewswire.com//news-release/2023/12/18/2797730/0/en/Lantheus-and-POINT-Biopharma-Announce-Positive-Topline-Results-from-Pivotal-SPLASH-Trial-in-Metastatic-Castration-Resistant-Prostate-Cancer.html
https://www.fiercebiotech.com/biotech/point-breaks-open-phase-3-data-showing-how-drug-14b-lilly-buyout-saga-matches-pluvicto
https://www.reuters.com/markets/deals/lilly-extends-tender-offer-acquire-point-biopharma-dec-1-2023-11-17/
https://www.prnewswire.com/news-releases/lilly-announces-the-receipt-of-nrc-consent-in-connection-with-its-proposed-acquisition-of-point-biopharma-301988209.html
https://www.globenewswire.com//news-release/2023/11/13/2778941/0/en/POINT-Biopharma-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Highlights.html
https://www.fiercebiotech.com/biotech/lilly-makes-splash-surfing-radiopharmaceutical-wave-14b-acquisition
https://www.globenewswire.com//news-release/2023/09/18/2744730/0/en/POINT-Biopharma-and-Athebio-Announce-Partnership-to-Develop-Designed-Ankyrin-Repeat-Protein-Targeted-Radioligands.html
https://www.globenewswire.com/news-release/2023/08/14/2724288/0/en/POINT-Biopharma-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Highlights.html
Market Place
Share 
